Choice of medical therapy to lower triglycerides in those at risk of pancreatitis

Preiss, D. and Sattar, N. (2013) Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Current Opinion in Lipidology, 24(6), pp. 532-533. (doi:10.1097/MOL.0000000000000029)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1097/MOL.0000000000000029

Abstract

The relationship between triglyceride levels and cardiovascular risk remains complex with large, high-quality epidemiological studies indicating that triglyceride levels do not predict risk beyond other lipids and usual classical risk factors, whereas studies of genetic polymorphisms suggest that triglycerides-related pathways may indeed have a causal factor. Statin therapy remains first-line therapy for cardiovascular risk reduction regardless of triglyceride levels.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Preiss, Dr David and Sattar, Professor Naveed
Authors: Preiss, D., and Sattar, N.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Current Opinion in Lipidology
Publisher:Lippincott Williams & Wilkins
ISSN:0957-9672
ISSN (Online):1473-6535

University Staff: Request a correction | Enlighten Editors: Update this record